Latest News
Axon Q1 Revenue Soars 34% on AI and Drone Demand, Guidance Raised
Axon Q1 revenue surged 34% to $807 million, beating estimates, as AI product revenue jumped over 700% and drone demand boosted outlook.
Snap Stock Falls 5% After Q1 Revenue Beat, Cautious Q2 Outlook, and End of Perplexity AI Deal
Snap Inc. reported Q1 revenue up 12% to $1.53B and 483M daily active users, but shares fell 5% after a cautious Q2 outlook and the end of the $400M Perplexity AI deal.
Coherent Stock Dips Despite Strong AI-Driven Q3 Results
Coherent Corp. shares dropped 6% after hours despite beating Q3 revenue estimates at $1.81B, driven by AI infrastructure demand. Wall Street focused on weak cash flow and margin misses.
AppLovin Shares Slide Despite Q1 Beat as Investors Eye Growth Sustainability
AppLovin reported Q1 revenue of $1.84B, up 59% YoY, and net income of $1.21B, more than doubling. Shares dropped 2.3% after hours as investors question long-term growth.
Loblaw Stock Dips 5% as Q1 Revenue Miss Overshadows Profit Growth
Loblaw reported Q1 revenue of C$14.48B, missing forecasts, sending shares down 5%. Net earnings rose to C$594M, and the company raised its dividend by 10% while approving a new buyback.
Beyond Meat Tops $1 Ahead of Q1 Results, Nasdaq Compliance in Focus
Beyond Meat shares reclaimed the $1 mark ahead of first-quarter earnings, but Nasdaq compliance pressure remains as the company faces a deadline to boost its stock price.
Compass Shares Surge 26% on Q1 Profit and Upbeat Q2 Forecast After Anywhere Deal
Compass Inc. shares surged 26% after reporting a first-quarter profit and issuing a strong second-quarter revenue forecast, boosted by its Anywhere Real Estate acquisition.
Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline
Bayer acquires Perfuse Therapeutics for up to $2.45 billion to secure Phase II eye drug PER-001, aiming to bolster its ophthalmology unit as Eylea sales slip.
NICE Ltd Shares Slump 23% on Weak Q2 Forecast Despite AI Growth
NICE Ltd shares tumbled 22.9% to $96.35 after Q2 revenue guidance fell short of expectations, despite a Q1 earnings beat and strong AI recurring revenue growth of 66%.
NANO Nuclear Soars on Supermicro Pact for AI Data Center Power
NANO Nuclear Energy shares jumped 24.6% after announcing a non-binding MOU with Super Micro Computer to explore powering AI data centers with microreactors. No final contracts or reactor approvals have been secured yet.
Ernexa Therapeutics Surges 60% on Promising Ovarian Cancer Preclinical Data
Ernexa Therapeutics shares jumped about 60% after the company announced its ERNA-101 cell therapy plus PD-1 blockade eliminated tumors and achieved 100% long-term survival in preclinical ovarian cancer models.